Value addition to Japanese technologies by GN Corp, featured in Government of Japan official website
10/5/2022
GNC’s activities are introduced in the Japan Cabinet Office’s site ‘Invest Japan’
News
A study of Nichi Glucan on children with autism has been published in Research Features Magazine
10/5/2022
This is the research on the potential of beta-glucan for autism
Rejuvenating human cartilage cells in the lab, proven by miRNA140 enhancement
6/3/2022
A breakthrough achievement on miRNA140 is published in Medicine Innovates
GN Corp track record published in Bloomberg
6/3/2022
An interview was published in a feature story in Bloomburg
Autism Sunday 2022: Commemoration and Panel discussion
4/2/2022
GN Corporation participates in the “Autism Sunday” to be held on February 13, 2022
NCRM NICHE 2021 and Fujio Cup Quiz on stem cells to be held virtually on 17th October 2021
17/10/2021
The NCRM NICHE 2021 is held virtually on 17 Oct 2021
Encouraging outcome of the clinical study on Beta Glucan for Covid-19 patients published
9/10/2021
This is the study on Beta glucan food supplements potential in Covid-19 patients
Probiotics and Prebiotics in human health; GNC to opine in Probiota Asia Summit 2021
28/9/2021
GNC particitates in Probiota Asia 2021 on 26 Oct 2022
NCRM NICHE 2021 and Fujio Cup Quiz on stem cells to be held virtually on 17th October 2021
4/9/2021
The NCRM NICHE 2021; commemorating the XVI Inaugur…
Press Release
Autologous immune-cell therapy practiced in Japan, helping Vinmec Hospital after technology transfer
16/10/2022
Technology transfer on cell therapy to Vietnam by GN Corporation
Webiner on “Cell Therapy Approaches for Urethral Stricture” jointly held with Edogawa Hospital
1/10/2022
Webiner on Cell Therapy Approaches for Urethral Stricture is held
Paper on Potential of Beta-Glucan Products to Prevent and Treat Non-Alcoholic Fatty Liver Disease
1/10/2022
A look at the potential of beta-glucan for the growing